SRC-1 has the second-most potent effect in prostate cancer, as the prostate is rich in endogenous androgen, which regulates various physiological activities through the androgen receptor (AR), and SRC-1 is a crucial mediated of these effects. This evidence concerns the gene NCOA1 and prostate carcinoma.